CATEGORIES

Editors Choice

LATEST

TRENDING

EDITORS CHOICE

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

Were the Billions Invested in Alzheimer’s Research Worthwhile?

It may seem that the COVID-19 vaccines appeared almost suddenly, like rabbits pulled from a magician’s hat, but the invention of mRNA-based vaccines that...

It’s About Time: CDC Changes COVID Isolation Guidelines

At Long last. The CDC has updated its guidelines with respect to Covid isolation. This has been a long time coming, and many in our...

Pro Tips to Reduce Your Stroke Risk

The lifetime risk of stroke for adult men and women (25 years of age and older) is approximately 25 percent. Worldwide, stroke is the second most common cause of mortality and the second most common cause of disability.